Deborah Ann Rodriguez, MD | |
34503 9th Ave South, #220, Federal Way, WA 98003 | |
(253) 927-3243 | |
(253) 627-0855 |
Full Name | Deborah Ann Rodriguez |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 34503 9th Ave South, Federal Way, Washington |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306932405 | NPI | - | NPPES |
8265290 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MD00038294 (Washington) | Primary |
Entity Name | Multicare Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
NantWorks, Inc. and Sorrento Therapeutics, Inc., announced today that they have entered into a binding agreement to initiate a global collaboration to discover and develop novel anti-cancer immunotherapies derived from Sorrento's proprietary G-MAB library against neoepitopes of tumor-specific antigens discovered using NantWorks' proprietary pan-omics based, precision medicine approach.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."
Researchers from the Centre for Cancer Biology at the University of South Australia have found that a deficiency of caspase-2 enzymes place people at a higher risk of developing tumours.
Aetna today commended the U.S. Senate for taking action to significantly expand access to health care coverage for millions of Americans. While noting progress toward meaningful reform, Aetna Chairman and CEO Ronald A. Williams said that more needs to be done to deliver on the full promise of health care system reform.
Cognoa's app helps every parent find out if their child's development is on track and, if not, get their child the right help as early as possible.
› Verified 3 days ago
Entity Name | My Catholic Doctor Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396201307 PECOS PAC ID: 7214367101 Enrollment ID: O20201207002031 |
News Archive
NantWorks, Inc. and Sorrento Therapeutics, Inc., announced today that they have entered into a binding agreement to initiate a global collaboration to discover and develop novel anti-cancer immunotherapies derived from Sorrento's proprietary G-MAB library against neoepitopes of tumor-specific antigens discovered using NantWorks' proprietary pan-omics based, precision medicine approach.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."
Researchers from the Centre for Cancer Biology at the University of South Australia have found that a deficiency of caspase-2 enzymes place people at a higher risk of developing tumours.
Aetna today commended the U.S. Senate for taking action to significantly expand access to health care coverage for millions of Americans. While noting progress toward meaningful reform, Aetna Chairman and CEO Ronald A. Williams said that more needs to be done to deliver on the full promise of health care system reform.
Cognoa's app helps every parent find out if their child's development is on track and, if not, get their child the right help as early as possible.
› Verified 3 days ago
Entity Name | My Catholic Doctor Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396201307 PECOS PAC ID: 7214367101 Enrollment ID: O20230720003821 |
News Archive
NantWorks, Inc. and Sorrento Therapeutics, Inc., announced today that they have entered into a binding agreement to initiate a global collaboration to discover and develop novel anti-cancer immunotherapies derived from Sorrento's proprietary G-MAB library against neoepitopes of tumor-specific antigens discovered using NantWorks' proprietary pan-omics based, precision medicine approach.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."
Researchers from the Centre for Cancer Biology at the University of South Australia have found that a deficiency of caspase-2 enzymes place people at a higher risk of developing tumours.
Aetna today commended the U.S. Senate for taking action to significantly expand access to health care coverage for millions of Americans. While noting progress toward meaningful reform, Aetna Chairman and CEO Ronald A. Williams said that more needs to be done to deliver on the full promise of health care system reform.
Cognoa's app helps every parent find out if their child's development is on track and, if not, get their child the right help as early as possible.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Deborah Ann Rodriguez, MD 316 Martin Luther King Jr Way, #212, Tacoma, WA 98405 Ph: (253) 383-5777 | Deborah Ann Rodriguez, MD 34503 9th Ave South, #220, Federal Way, WA 98003 Ph: (253) 927-3243 |
News Archive
NantWorks, Inc. and Sorrento Therapeutics, Inc., announced today that they have entered into a binding agreement to initiate a global collaboration to discover and develop novel anti-cancer immunotherapies derived from Sorrento's proprietary G-MAB library against neoepitopes of tumor-specific antigens discovered using NantWorks' proprietary pan-omics based, precision medicine approach.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."
Researchers from the Centre for Cancer Biology at the University of South Australia have found that a deficiency of caspase-2 enzymes place people at a higher risk of developing tumours.
Aetna today commended the U.S. Senate for taking action to significantly expand access to health care coverage for millions of Americans. While noting progress toward meaningful reform, Aetna Chairman and CEO Ronald A. Williams said that more needs to be done to deliver on the full promise of health care system reform.
Cognoa's app helps every parent find out if their child's development is on track and, if not, get their child the right help as early as possible.
› Verified 3 days ago
Catherine Delostrinos, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 301 S 320th St, Federal Way, WA 98003 Phone: 253-874-7000 | |
Corrie L Takahashi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 33501 1st Way S, Ms: A-so, Federal Way, WA 98003 Phone: 253-838-2400 Fax: 253-874-1637 | |
Pamela L. Mouser, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 301 S 320th St, Federal Way, WA 98003 Phone: 253-874-7000 | |
John Apostol, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 34503 9th Ave South, #220, Federal Way, WA 98003 Phone: 253-927-3243 Fax: 253-627-0855 | |
Jonathan R Fox, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 33501 1st Way S, Federal Way, WA 98003 Phone: 253-838-2400 | |
Minh-y Ngoc Canh, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 33431 13th Pl S, Federal Way, WA 98003 Phone: 253-815-8040 |